Article Text

Download PDFPDF
No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome
  1. Brent Taylor1,
  2. Nick Andrews2,
  3. Julia Stowe1,
  4. Laila Hamidi-Manesh1,
  5. Elizabeth Miller3
  1. 1
    General and Adolescent Paediatric Unit, Institute of Child Health, University College London, London, UK
  2. 2
    Statistics, Modelling and Bioinformatics Department, Health Protection Agency Centre for Infections, London, UK
  3. 3
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
  1. Elizabeth Miller, Immunisation Department, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK; liz.miller{at}hpa.org.uk

Footnotes

  • JS is supported by DoH Research and Development Directorate grant 1216520.

  • Competing interests: EM’s department has received reimbursement for meningococcal C surveillance reports to vaccine manufacturers in accordance with the code of practice for the department (see http://www.hpa.org.uk/infections/about/dir/psp.pdf). There are no other conflicts of interest.

  • Ethics: The linked data adverse vaccination events programme has MREC and Patient Information Advisory Group approval.

  • Contributions of authors: EM, NA and BT designed the study, JS and LH-M identified the case notes and processed the data, BT assessed relapses, NA undertook the statistical analyses and all authors contributed to writing the paper.

  • Abbreviations:
    CI
    confidence interval
    GOSH
    Great Ormond Street Hospital
    IRR
    incidence rate ratio
    MCCV
    meningococcal C conjugate vaccine
    MHRA
    Medicines and Healthcare Products Regulatory Agency
View Full Text

Statistics from Altmetric.com

Footnotes

  • JS is supported by DoH Research and Development Directorate grant 1216520.

  • Competing interests: EM’s department has received reimbursement for meningococcal C surveillance reports to vaccine manufacturers in accordance with the code of practice for the department (see http://www.hpa.org.uk/infections/about/dir/psp.pdf). There are no other conflicts of interest.

  • Ethics: The linked data adverse vaccination events programme has MREC and Patient Information Advisory Group approval.

  • Contributions of authors: EM, NA and BT designed the study, JS and LH-M identified the case notes and processed the data, BT assessed relapses, NA undertook the statistical analyses and all authors contributed to writing the paper.

  • Abbreviations:
    CI
    confidence interval
    GOSH
    Great Ormond Street Hospital
    IRR
    incidence rate ratio
    MCCV
    meningococcal C conjugate vaccine
    MHRA
    Medicines and Healthcare Products Regulatory Agency

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Précis
    BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health